One in the Same After a Long Battle

14Jun2:10 pmEST

By the Way, That's Not Mom and Pop Buying Zynga

Much like Pandora, Zynga seems to get no respect from traders even on up-days and even, as the daily chart illustrates below, the technicals are improving as a whole. ZNGA has been hot since the first day of May, with surging buy volume to support the move. Despite being a low-priced stock, there were multiple sessions where more than 25...

14Jun10:43 amEST

An Interesting Location for the World Cup

No, I am not referring to the host country of this World Cup, which is getting underway this morning. Instead, I am talking about the price location of Yandex, Russia's version of Google, essentially. And if you subscribe to the idea that Google is somewhat of a proxy for U.S. (or global) GDP, then it is hard not see YNDX as a potential long...

13Jun3:50 pmEST

Stock Market Recap 06/13/18 {Video}

The following video is a brief, condensed version of the Stock Market Recap which I present each evening to members of Market Chess Subscription Services. In the longer version, I offer tons of actionable trade ideas, educational content, and in-depth objective analysis across all markets. If you enjoy my videos and blog posts, then please...

13Jun3:48 pmEST

Saving the Waterfall Jumper

The initial spike lower that GDXJ (ETF for junior gold miners) suffered after the FOMC decision at 2pm EST today had larger implications, too. As you can see on the GDXJ daily chart, below, juniors have been rather compressed for a few months now, with plenty of fits and starts keeping traders like myself mostly at bay and not being too...

13Jun1:12 pmEST

Do Not Nuke the Nukes Yet

(Pictured above, Julius Robert Oppenheimer, often known as father of the atomic bomb) The fact that a stock like Cameco, updated below on its daily chart, not only failed to swoon in the face of the recent Trump/North Korea headlines signaling a major global development in peace, but is actually coiling and ripe for an explosion (er,...

13Jun10:18 amEST

Taking a Break Way Up There

The stock for Cambridge, Massachusetts-based biopharma Sarepta Therapeutics Inc. has been more than commendable this spring, as many of its peers saw their stocks struggle. Even many of the bios which had held up well took the brunt of a volatile ASCO conference this year and suffered sharp drawdowns, namely BPMC NKTR, among others. Thus, when...

12Jun3:19 pmEST

Somewhat Dead Ahead of the Fed

While momentum traders seeking intraday hot action are piling into the likes of FIT RH TSLA today, among a few other monster movers like SAGE, the general tone and tenor of the broad market action this afternoon has me thinking the market will slow down and drift into the FOMC event which truly begins after 2pm EST. Although the beginning of...

12Jun10:36 amEST

You Adapt, Evolve, Compete, or Die

An extremely rare interview on CNBC this morning with the legendary trader and hedge fund investor, Paul Tudor Jones, had me recalling his many famous quotes regarding markets. One of my favorite ones is, “You adapt, evolve, compete or die," implying that traders must constantly be willing to change their minds to keep up with ever-changing...

11Jun5:07 pmEST

Stock Market Recap 06/11/18 {Video}

The following video is a brief, condensed version of the Stock Market Recap which I present each evening to members of Market Chess Subscription Services. In the longer version, I offer tons of actionable trade ideas, educational content, and in-depth objective analysis across all markets. If you enjoy my videos and blog posts, then please...

11Jun2:16 pmEST

One in the Same After a Long Battle

As we work our way through the heart of afternoon trading, rotation seems to be the name of the game as small caps lag while other parts of the market attempt to benefit from inflows. On that note about rotation, it is interesting to see two long-time, high beta laggards finally sustain rallies. FitBit has been on a tear since early-May,...